The company says the test revealed patients were experiencing 'deepening and durability of response over time' with the treatment.
The cloud-based life sciences industry software provider issues guidance in line with expectations.
Shares of medical device maker Soliton soar for a second day after the Food and Drug Administration approved its device for tattoo removal.
A look at the charts and indicators of three big names in the sector .
Let's check the charts and indicators.
Shares of Puma Biotechnology plunge after the company reveals that more patients than expected have discontinued treatment with its breast cancer drug, Nerlynx, prompting several analyst downgrades.
The all-cash acquisition is part of an effort to expand into an adjacent self-care product category, Perrigo says.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.